pentazirinocyclodiphosphathiazene and Bone Marrow Diseases

pentazirinocyclodiphosphathiazene has been researched along with Bone Marrow Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mulder, NH; Rodenhuis, S; Schraffordt Koops, H; Sleijfer, DT; Van de Grampel, JC	1

Other Studies

1 other study(ies) available for pentazirinocyclodiphosphathiazene and Bone Marrow Diseases

Article	Year
Phase I evaluation of SOAz (1,3,3,5,5 pentakis(aziridino)-1 lambda 6, 2,4,6,3 lambda 5, 5 lambda 5 thiatriaza-diphosphorine-1-oxide) in a weekly schedule. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Azirines; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thrombocytopenia	1984

Article

Year

Phase I evaluation of SOAz (1,3,3,5,5 pentakis(aziridino)-1 lambda 6, 2,4,6,3 lambda 5, 5 lambda 5 thiatriaza-diphosphorine-1-oxide) in a weekly schedule.

European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:5

Topics: Adult; Aged; Antineoplastic Agents; Azirines; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thrombocytopenia

1984